VFMCRP and ChemoCentryx report positive data for avacopan

The Phase III ADVOCATE trial assessed avacopan in a total of 331 patients. Credit: Vifor Pharma Management Ltd.



  • VFMCRP, ChemoCentryx report positive Phase III data for avacopan